REGENERON PHARMACEUTICALS, INC. Accounts Payable 2017-2026 | REGN
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is REGENERON PHARMACEUTICALS, INC.'s current accounts payable?
REGENERON PHARMACEUTICALS, INC. (REGN) annual accounts payable for 2025 was $939.0M, a 18.94% increase from 2024. REGENERON PHARMACEUTICALS, INC. accounts payable for the quarter ending March 31, 2026 was $1.03B.
What was REGENERON PHARMACEUTICALS, INC.'s accounts payable in 2024?
REGENERON PHARMACEUTICALS, INC. annual accounts payable for 2024 was $789.5M, a 30.15% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s accounts payable in 2023?
REGENERON PHARMACEUTICALS, INC. annual accounts payable for 2023 was $606.6M, a 2.95% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year accounts payable CAGR?
REGENERON PHARMACEUTICALS, INC. accounts payable grew at a compound annual growth rate (CAGR) of 14.58% from FY2020 to FY2025, going from $475.5M to $939.0M over 5 years.
Year-over-year comparison from 10-K annual reports